Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) Tops Q1 EPS by 31c; Lowers FY20 Guidance, Raises Dividend

April 14, 2020 6:32 AM

(Updated - April 14, 2020 6:34 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.30, $0.31 better than the analyst estimate of $1.99. Revenue for the quarter came in at $20.69 billion versus the consensus estimate of $19.44 billion.

GUIDANCE:

Johnson & Johnson sees FY2020 EPS of $7.50-$7.90, versus the consensus of $8.08. Johnson & Johnson sees FY2020 revenue of $77.5-80.5 billion, versus the consensus of $79.63 billion.

The impact of COVID-19, inclusive of the related investments the Company is making to combat the pandemic, is included in the guidance below.

April 2020

January 2020

($ in Billions, except EPS)

Adjusted Operational Sales1,2

Change vs. Prior Year

(3.0%) - 0.5%

5.0% - 6.0%

Operational Sales2

Change vs. Prior Year

$79.2 to $82.2

(3.5%) - 0.0%

$85.8 to $86.6

4.5% - 5.5%

Estimated Reported Sales3

Change vs. Prior Year

$77.5 to $80.5

(5.5%) - (2.0%)

$85.4 to $86.2

4.0% - 5.0%

Adjusted Operational EPS (Diluted)2,4

Change vs. Prior Year

$7.65 to $8.05

(11.9%) - (7.3%)

$9.00 to $9.15

3.7% - 5.4%

Adjusted EPS (Diluted)3,4

Change vs. Prior Year

$7.50 to $7.90

(13.6%) - (9.0%)

$8.95 to $9.10

3.1% - 4.8%

With earnings, Johnson & Johnson raised its quarterly dividend $1.01 per share, or $4.04 annualized. This is a 6.3% increase from the prior dividend of $0.95. The dividend will be payable on June 9, 2020, to stockholders of record on May 26, 2020, with an ex-dividend date of May 22, 2020. The annual yield on the dividend is 2.8 percent.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

Categories

Earnings Guidance Hot Earnings Hot Guidance

Next Articles